LIQUID BASED 

WHO

Diagnosed NSCLC patients

IDENTIFIES FOR

10 genes for multi-genetic biomarker

 

TURNAROUND TIME

6-10 working days

Re-Snap_Logo_.png
Re-Snap_Logo_.png
p-EGFR logo.png

WHO

Lung cancer patients 

SCREENS FOR

EGFR Exon 19 deletions, Exon 21 L858R, Exon 20 T790M, C797S mutations in  plasma

TURNAROUND TIME

2-3 working days

p-EGFR logo.png
p-EGFR logo.png
BRCA_Zoom®_Logo_version2.png

WHO

Breast, ovarian, prostate cancer patients 

SCREENS FOR

Mutated BRCA1 and BRCA2 - linked germline mutations

TURNAROUND TIME 

Within 20 working days

BRCA_Zoom®_Logo_version2.png
image001.png

WHO

Patients with advanced -solid tumours  

IDENTIFIES FOR

74 genes with somatic mutations with reports on micro-satelitte instability status. ​

TURNAROUND TIME 

Within 7 days of sample receipt in the US laboratory 

+

​3 days logistics

image001.png

TISSUE BASED

PDL1.png

WHO

NSCLC, gastric, endothelial and cervical cancer patients 

DETECTS

Proportion of PD-L1 positive cell expression 

TURNAROUND TIME

8 working days

PDL1.png
OncoSnap®Pro_Logo.png

WHO

Solid tumour patients 

PROFILES FOR

466 genes for single nucleotide variations, insertions, deletions, selected fusions and copy number alternations

TURNAROUND TIME

14 working days

OncoSnap®Pro_Logo.png
OncoSnapBRCA_version2.png

WHO

Breast, ovarian, prostate cancer patients 

SCREENS FOR

Somatic mutations of BRCA1 and BRA2 genes

TURNAROUND TIME

14 working days

OncoSnapBRCA_version2.png
Nonet Logo_version2.png

WHO

Primarily diagnosed NSCLC patients 

SCREENS FOR

9 genes for multi-genetic biomarkers

TURNAROUND TIME

3-5 working days

Nonet Logo Final v.1.png

PREIMPLANTATION GENETIC SCREENING

EmbryoSafe孕兒安logo_outlined.png

WHO

Females over 35, history of failed implantations, miscarriages or chromosomal abnormalities 

SCREENS FOR

 24 chromosomes of IVF and ICSI embryos to detect pathogenic chromosome copy number changes

TURNAROUND TIME 

5-9 working days

EmbryoSafe孕兒安logo_outlined.png